DHL has broken ground on a new cold chain hub at Singapore’s Changi Airport, marking a significant expansion of its pharmaceutical logistics capabilities in Asia. The new facility underlines growing demand for
Pennsylvania has enacted sweeping new legislation governing the decommissioning of commercial solar energy facilities, replacing a fragmented system of local regulations with a uniform statewide framework. Act 44 of 2026, signed into
More
JP Morgan has raised its price target for Ocado Group PLC (LSE:OCDO) to 290p from 245p, reaffirming its overweight rating on the stock. Analyst Marcus Diebel argues the market is valuing the
More
The promise of AI-driven deflation remains a distant dream as mounting infrastructure costs push prices higher across the US economy right now. Silicon Valley executives including OpenAI CEO Sam Altman and Tesla
More
Prime Minister Andy Burnham will chair an emergency Cobra meeting to coordinate the government’s response to this summer’s extreme heat and worsening drought conditions. The meeting will bring together ministers overseeing health,
More
Snapchat has unveiled a new advertising format designed specifically for pharmaceutical marketers, making it easier to include required product disclosures within in-feed ads. The updated format allows pharma advertisers to attach product
More
The US Senate confirmed two National Labor Relations Board members on August 7, 2026, reshaping the balance of power at the influential labour regulator. David Prouty, first appointed to the NLRB by
More
The legal industry has broadly embraced artificial intelligence, but the pace of adoption is running well ahead of the professional judgment needed to use it responsibly. Comfort with AI tools has grown
More
Joby Aviation (JOBY) saw its shares fall roughly 4% as investors reacted cautiously to news of a major defence acquisition and a planned stock sale. The company announced a $500 million defence-related
More
British retail investors have long turned their backs on domestic equities, but 2026 is shaping up to be a genuine turning point for the UK market. At the end of 2024, domestic
More
Scholar Rock has removed Novo Nordisk’s Catalent manufacturing facility from its FDA submission for apitegromab, a spinal muscular atrophy treatment candidate, following a damaging inspection outcome. The troubled plant received an “Official
More